Skip to main content
FinSpry Logo
FinSpry
PCRX logo
PCRX
(NASDAQ)
Pacira BioSciences, Inc.
$24.67-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Pacira BioSciences (PCRX) Stock Price & Financial Analysis

Pacira BioSciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$23.66 - $24.72
52-Week High$27.66
52-Week Low$18.80
Open$23.91
Volume465.76K
Average Volume (3M)622.97K
Market Cap1.01B
Shares Outstanding40.91M
P/E Ratio (TTM)185.04
Price to Sales (P/S)1.29
Price to Book (P/B)1.45
EV/EBITDA9.47
Revenue (TTM)734.86M
Net Income (TTM)5.14M
Free Cash Flow (TTM)132.71M
EPS (TTM)$0.12
Profit Margin0.70%
Operating Margin3.09%
Return on Equity (ROE)0.79%
Debt to Equity0.58
50-Day MA$24.77
200-Day MA$23.62
52-Week Change-6.21%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Pacira BioSciences

What is the current stock price for PCRX?

As of the latest trading session, PCRX stock trades at $24.67. The 52-week range is $18.80–$27.66, with a day range of $23.66–$24.72.

What is the P/E ratio for PCRX?

Pacira BioSciences's trailing P/E ratio is 185.0, meaning investors pay $185.0 for every $1 of annual earnings. Pacira BioSciences operates in the Healthcare sector.

Does PCRX pay dividends?

Pacira BioSciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PCRX?

Based on 2 analysts, the consensus for PCRX is Buy.

What is the market cap of PCRX?

Pacira BioSciences's market capitalization is $1.01B, classifying it as a small-cap company. Pacira BioSciences operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.